Patients with rarer types of diabetes can get up to 80% in subsidies for monitoring devices

Rarer diabetes patients in Singapore can now receive up to 80% government subsidies for continuous glucose monitoring (CGM) ...
IEEE Spectrum on MSN

Why the most accurate glucose monitors are failing some users

In late November Abbott—one of Dexcom’s main competitors— recalled some of its CGMs due to inaccurate low glucose readings. The recall affects approximately 3 million sensors and was caused by an ...
Drug Delivery Business

Diabeloop wins FDA nod for new automated insulin delivery algorithm

Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance.
Drug Delivery Business

Dexcom to cease G6 CGM production next year, transition fully to G7

A Dexcom (NSDQ:DXCM) communication on its website states that it will soon cease manufacturing for its G6 continuous glucose ...